These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7484482)

  • 1. Improvements in exercise capacity and dyspnoea by inhaled anticholinergic drug in elderly patients with chronic obstructive pulmonary disease.
    Teramoto S; Fukuchi Y
    Age Ageing; 1995 Jul; 24(4):278-82. PubMed ID: 7484482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of inhaled anticholinergic drug on dyspnea and gas exchange during exercise in patients with chronic obstructive pulmonary disease.
    Teramoto S; Fukuchi Y; Orimo H
    Chest; 1993 Jun; 103(6):1774-82. PubMed ID: 8404100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of inhaled anticholinergic drug on lung function, dyspnea, and exercise capacity in patients with chronic obstructive pulmonary disease.
    Teramoto S; Matsuse T; Sudo E; Ohga E; Katayama H; Suzuki M; Ouchi Y; Fukuchi Y
    Intern Med; 1996 Oct; 35(10):772-8. PubMed ID: 8933184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of aerosol oxitropium bromide and fenoterol on maximal exercise capacity in chronic obstructive pulmonary disease and their correlation with air flow during exercise and with parameters of maximal exercise].
    Suruda T; Nakamura H; Kobayashi H; Uetani K; Nishio M; Higashimoto Y; Funasako M; Ohata M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Sep; 31(9):1089-95. PubMed ID: 8255017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of inhaled anticholinergic drug on pulmonary function and quality of life in elderly patients with chronic obstructive pulmonary disease].
    Teramoto S
    Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):519-22. PubMed ID: 11523165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests.
    Oga T; Nishimura K; Tsukino M; Hajiro T; Ikeda A; Izumi T
    Am J Respir Crit Care Med; 2000 Jun; 161(6):1897-901. PubMed ID: 10852763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxitropium bromide improves exercise performance in patients with COPD.
    Ikeda A; Nishimura K; Koyama H; Sugiura N; Izumi T
    Chest; 1994 Dec; 106(6):1740-5. PubMed ID: 7988193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of inhaled anticholinergic drug on dyspnea and on the physiologic function of respiratory system in patients with chronic obstructive pulmonary disease].
    Teramoto S; Suzuki M; Matsuse T; Ohga E; Katayama H; Fukuchi Y; Ouchi Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Nov; 35(11):1209-14. PubMed ID: 9493448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.
    O'Donnell DE; Flüge T; Gerken F; Hamilton A; Webb K; Aguilaniu B; Make B; Magnussen H
    Eur Respir J; 2004 Jun; 23(6):832-40. PubMed ID: 15218994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease.
    O'Donnell DE; Lam M; Webb KA
    Am J Respir Crit Care Med; 1999 Aug; 160(2):542-9. PubMed ID: 10430726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease.
    Tsukino M; Nishimura K; Ikeda A; Hajiro T; Koyama H; Izumi T
    Thorax; 1998 Apr; 53(4):269-73. PubMed ID: 9741369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.
    Casaburi R; Kukafka D; Cooper CB; Witek TJ; Kesten S
    Chest; 2005 Mar; 127(3):809-17. PubMed ID: 15764761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of the anticholinergic agent oxitropium bromide in elderly patients with bronchial asthma.
    Shioya T; Kagaya M; Onodera A; Miura S; Shindo T; Sano M; Sasaki M; Miura M
    Arzneimittelforschung; 1996 Dec; 46(12):1130-3. PubMed ID: 9006786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of inhaled oxitropium bromide, an anticholinergic drug, on pulmonary hemodynamics in patients with chronic obstructive pulmonary diseases].
    Saito S; Miyamoto K; Aida A; Saito H; Sato F; Tsujino I; Nakano T; Nishimura M; Kawakami Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Sep; 33(9):924-9. PubMed ID: 8538086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease.
    Cazzola M; Di Perna F; Centanni S; Califano C; Donner CF; D'Amato M; D'Amato G
    Thorax; 1999 Dec; 54(12):1083-6. PubMed ID: 10567627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen desaturation and breathlessness during corridor walking in chronic obstructive pulmonary disease: effect of oxitropium bromide.
    Spence DP; Hay JG; Carter J; Pearson MG; Calverley PM
    Thorax; 1993 Nov; 48(11):1145-50. PubMed ID: 8296259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response study of oxitropium bromide inhaled as a nebulised solution.
    Stappaerts I; Van Schil L; Van der Veken J
    Eur J Clin Pharmacol; 1994; 46(4):305-7. PubMed ID: 7957513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease.
    Wijkstra PJ; TenVergert EM; van der Mark TW; Postma DS; Van Altena R; Kraan J; Koëter GH
    Thorax; 1994 May; 49(5):468-72. PubMed ID: 8016768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.